Transplacental Distribution of Lidocaine and Its Metabolite in Peridural Anesthesia Administered to Patients With Gestational Diabetes Mellitus.

Autor: Moises EC; Department of Gynecology and Obstetrics, Faculty of Medicine of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil elainemoises@hcrp.fmrp.usp.br., Duarte Lde B; Women and Children Department, Fluminense Federal University, Rio de Janeiro, Brazil., Cavalli Rde C; Department of Gynecology and Obstetrics, Faculty of Medicine of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Carvalho DM; Department of Gynecology and Obstetrics, Faculty of Medicine of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Filgueira GC; Department of Gynecology and Obstetrics, Faculty of Medicine of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Marques MP; Department of Clinical Analysis, Toxicology and Food Sciences, Faculty of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Lanchote VL; Department of Clinical Analysis, Toxicology and Food Sciences, Faculty of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Duarte G; Department of Gynecology and Obstetrics, Faculty of Medicine of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.
Jazyk: angličtina
Zdroj: Reproductive sciences (Thousand Oaks, Calif.) [Reprod Sci] 2015 Jul; Vol. 22 (7), pp. 791-7. Date of Electronic Publication: 2015 Jan 05.
DOI: 10.1177/1933719114561560
Abstrakt: Background: Neonatal effects of drugs administered to mothers before delivery depend on the quantity that crosses the placental barrier, which is determined by the pharmacokinetics of the drug in the mother, fetus, and placenta. Diabetes mellitus can alter the kinetic disposition and the metabolism of drugs. This study investigated the placental transfer of lidocaine and its metabolite monoethylglycinexylidide (MEGX) in pregnant women with gestational diabetes mellitus (GDM) submitted to peridural anesthesia.
Patients and Methods: A total of 10 normal pregnant women (group 1) and 6 pregnant women with GDM (group 2) were studied, all at term. The patients received 200 mg 2% lidocaine hydrochloride by the peridural locoregional route. Maternal blood samples were collected at the time of delivery and, after placental expulsion, blood samples were collected from the intervillous space, umbilical artery, and vein for determination of lidocaine and MEGX concentrations and analysis of the placental transfer of the drug.
Results: The following respective lidocaine ratios between the maternal and the fetal compartments were obtained for groups 1 and 2: umbilical vein/maternal peripheral blood, 0.60 and 0.46; intervillous space/maternal blood, 1.01 and 0.88; umbilical artery/umbilical vein, 0.77 and 0.91; and umbilical vein/intervillous space, 0.53 and 0.51. The following MEGX ratios for groups 1 and 2 were, respectively, fetal/maternal, 0.43 and 0.97; intervillous space/maternal blood, 0.64 and 0.90; umbilical artery/umbilical vein, 1.09 and 0.99; and umbilical vein/intervillous space, 0.55 and 0.78.
Conclusion: Gestational diabetes mellitus did not affect the transplacental transfer of lidocaine but interfered with the transfer of MEGX, acting as a mechanism facilitating the transport of the metabolite.
(© The Author(s) 2015.)
Databáze: MEDLINE
Externí odkaz: